HK1146722A1 - Equilibrative nucleoside transporter ent1 inhibitors - Google Patents
Equilibrative nucleoside transporter ent1 inhibitorsInfo
- Publication number
- HK1146722A1 HK1146722A1 HK11100813.2A HK11100813A HK1146722A1 HK 1146722 A1 HK1146722 A1 HK 1146722A1 HK 11100813 A HK11100813 A HK 11100813A HK 1146722 A1 HK1146722 A1 HK 1146722A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- nucleoside transporter
- equilibrative nucleoside
- inhibitors
- transporter ent1
- ent1 inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07120630 | 2007-11-14 | ||
PCT/EP2008/065438 WO2009062990A2 (en) | 2007-11-14 | 2008-11-13 | Equilibrative nucleoside transporter ent1 inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1146722A1 true HK1146722A1 (en) | 2011-07-08 |
Family
ID=39145373
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK11100813.2A HK1146722A1 (en) | 2007-11-14 | 2011-01-26 | Equilibrative nucleoside transporter ent1 inhibitors |
Country Status (18)
Country | Link |
---|---|
US (1) | US8263592B2 (zh) |
EP (1) | EP2209790B1 (zh) |
JP (1) | JP5369108B2 (zh) |
KR (1) | KR101598136B1 (zh) |
CN (1) | CN101855224B (zh) |
AR (1) | AR069304A1 (zh) |
AU (1) | AU2008322960B2 (zh) |
BR (1) | BRPI0820642B1 (zh) |
CA (1) | CA2704423C (zh) |
CL (1) | CL2008003383A1 (zh) |
EA (1) | EA017215B1 (zh) |
ES (1) | ES2569511T3 (zh) |
HK (1) | HK1146722A1 (zh) |
IL (1) | IL205710A (zh) |
JO (1) | JO3126B1 (zh) |
PA (1) | PA8803401A1 (zh) |
TW (1) | TWI437000B (zh) |
WO (1) | WO2009062990A2 (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201101959D0 (en) | 2011-02-04 | 2011-03-23 | Univ Nottingham | Novel ether linked compoundsand improved treatments for cardiac and cardiovascular disease |
CR20160578A (es) | 2014-06-26 | 2017-02-21 | Hoffmann La Roche | Derivados de indolin-2-ona o pirrolo-piridin-2-ona |
CN108137561B (zh) * | 2015-11-06 | 2021-03-26 | 豪夫迈·罗氏有限公司 | 二氢吲哚-2-酮衍生物 |
EP3371169B1 (en) | 2015-11-06 | 2019-07-17 | H. Hoffnabb-La Roche Ag | Indolin-2-one derivatives for use in the treatment of cns and related disorders |
CN108349944B (zh) | 2015-11-06 | 2021-03-30 | 豪夫迈·罗氏有限公司 | 二氢吲哚-2-酮衍生物 |
CN105802999B (zh) * | 2016-04-01 | 2019-05-03 | 中南大学湘雅医院 | 一种膜蛋白ENTs跨膜转运ODNs的试剂盒及方法 |
JP6879677B2 (ja) | 2016-05-26 | 2021-06-02 | 株式会社クボタ | 作業車 |
BR112019008516A2 (pt) | 2016-11-14 | 2019-07-09 | Jiangsu Hengrui Medicine Co | derivado de 3,4-bipiridil pirazol, e método de preparação para o mesmo e aplicação médica do mesmo |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9701396D0 (sv) * | 1997-04-15 | 1997-04-15 | Astra Pharma Prod | Compounds |
GB0003397D0 (en) * | 2000-02-14 | 2000-04-05 | Merck Sharp & Dohme | Therapeutic agents |
AU2003300124A1 (en) * | 2002-12-31 | 2004-07-29 | BUOLAMWINI, John, K | Novel nucleoside transport inhibitors |
JPWO2004101593A1 (ja) * | 2003-05-16 | 2006-07-13 | キッセイ薬品工業株式会社 | 5’−修飾ヌクレオシド誘導体及びその医薬用途 |
WO2005063788A1 (ja) * | 2003-12-26 | 2005-07-14 | Kissei Pharmaceutical Co., Ltd. | ベンズイミダゾール誘導体及びその医薬用途 |
EP1903960A2 (en) * | 2005-07-15 | 2008-04-02 | Children's Hospital Medical Center | Apparatus for minimally invasive posterior correction of spinal deformity |
TW200804393A (en) * | 2005-11-14 | 2008-01-16 | Solvay Pharm Gmbh | Novel N-sulfamoyl-N'-benzopyranpiperidines for medical use |
US7576207B2 (en) * | 2006-04-06 | 2009-08-18 | Adolor Corporation | Spirocyclic heterocyclic derivatives and methods of their use |
-
2008
- 2008-10-07 JO JOP/2008/0435A patent/JO3126B1/ar active
- 2008-11-07 PA PA20088803401A patent/PA8803401A1/es unknown
- 2008-11-13 AU AU2008322960A patent/AU2008322960B2/en not_active Ceased
- 2008-11-13 BR BRPI0820642-2A patent/BRPI0820642B1/pt not_active IP Right Cessation
- 2008-11-13 JP JP2010533574A patent/JP5369108B2/ja not_active Expired - Fee Related
- 2008-11-13 US US12/742,807 patent/US8263592B2/en active Active
- 2008-11-13 AR ARP080104950A patent/AR069304A1/es active IP Right Grant
- 2008-11-13 TW TW097143772A patent/TWI437000B/zh not_active IP Right Cessation
- 2008-11-13 KR KR1020107011152A patent/KR101598136B1/ko active IP Right Grant
- 2008-11-13 EA EA201070599A patent/EA017215B1/ru not_active IP Right Cessation
- 2008-11-13 WO PCT/EP2008/065438 patent/WO2009062990A2/en active Application Filing
- 2008-11-13 CA CA2704423A patent/CA2704423C/en active Active
- 2008-11-13 CN CN2008801159592A patent/CN101855224B/zh not_active Expired - Fee Related
- 2008-11-13 ES ES08849500.7T patent/ES2569511T3/es active Active
- 2008-11-13 EP EP08849500.7A patent/EP2209790B1/en active Active
- 2008-11-13 CL CL2008003383A patent/CL2008003383A1/es unknown
-
2010
- 2010-05-12 IL IL205710A patent/IL205710A/en active IP Right Grant
-
2011
- 2011-01-26 HK HK11100813.2A patent/HK1146722A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP2011503147A (ja) | 2011-01-27 |
JP5369108B2 (ja) | 2013-12-18 |
CA2704423C (en) | 2017-01-10 |
CN101855224B (zh) | 2012-11-28 |
CL2008003383A1 (es) | 2010-02-05 |
TW200936593A (en) | 2009-09-01 |
TWI437000B (zh) | 2014-05-11 |
AR069304A1 (es) | 2010-01-13 |
EA201070599A1 (ru) | 2010-12-30 |
ES2569511T3 (es) | 2016-05-11 |
KR101598136B1 (ko) | 2016-02-29 |
JO3126B1 (ar) | 2017-09-20 |
AU2008322960B2 (en) | 2013-02-07 |
WO2009062990A2 (en) | 2009-05-22 |
AU2008322960A1 (en) | 2009-05-22 |
IL205710A0 (en) | 2010-11-30 |
PA8803401A1 (es) | 2009-06-23 |
US8263592B2 (en) | 2012-09-11 |
BRPI0820642A2 (pt) | 2020-08-11 |
US20100280025A1 (en) | 2010-11-04 |
KR20100089088A (ko) | 2010-08-11 |
CA2704423A1 (en) | 2009-05-22 |
EA017215B1 (ru) | 2012-10-30 |
EP2209790A2 (en) | 2010-07-28 |
CN101855224A (zh) | 2010-10-06 |
IL205710A (en) | 2013-07-31 |
WO2009062990A3 (en) | 2009-09-24 |
BRPI0820642B1 (pt) | 2021-05-25 |
EP2209790B1 (en) | 2016-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL213698A0 (en) | Nucleoside phosphoramidates | |
IL205518A0 (en) | Distributed netork for performing complex algorithms | |
ZA201008829B (en) | Nucleoside cyclicphosphates | |
IL201379A0 (en) | Inhibitors iap | |
DK200800103A (en) | Integreret føringskant for vindturbineblad | |
EP2185745A4 (en) | THERMOCOUPLE | |
EP2196131A4 (en) | INTRODUCTION SYSTEM IN A SUBJECT | |
HK1176601A1 (zh) | 抑制劑 | |
EP2160129A4 (en) | FOR ADJUSTING TURNING CATHETERIZATION SYSTEM | |
EP2225667A4 (en) | REAL TIME COMMENTARY UNIT | |
ZA201003438B (en) | Antiviral nucleoside compounds | |
EP2069956A4 (en) | CENTRAL TV SYSTEM | |
HK1146722A1 (en) | Equilibrative nucleoside transporter ent1 inhibitors | |
GB0710995D0 (en) | Combines | |
GB0718255D0 (en) | Nucleobase characterisation | |
GB0710994D0 (en) | Combines | |
EP2029448A4 (en) | TRANSPORT APPARATUS | |
EP2023727A4 (en) | PROSTAGLANDINTRANSPORTER INHIBITORS | |
GB0709061D0 (en) | Expression system | |
GB0711032D0 (en) | Combines | |
DK200901203A (en) | Hydroponisk system | |
EP2222662A4 (en) | INHIBITORS OF KYNURENINE AMINO TRANSFERASE | |
HK1187256A1 (zh) | 降血壓劑 | |
TWM319832U (en) | Improved structure for pliers | |
HK1147354A1 (en) | Two-power-source system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20221115 |